• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Eleven Biotherapeutics

edit

Eleven Biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease.

Milestones

edit

• 
  Eleven Biotherapeutics added David Berry as Board Member.
  Posted 3/16/12 at 3:02pm
• 
  Eleven Biotherapeutics added Abbie Celniker as CEO.
  Posted 9/22/11 at 6:31pm
• 
  Eleven Biotherapeutics added Mark Levin as Interim CEO.
  Posted 3/8/10 at 10:34pm
• 
  Eleven Biotherapeutics received $20M in Series A funding. (5/8/12)
  Posted 5/8/12 at 5:03am via masshightech.com
• 
  Eleven Biotherapeutics received $35M in Series A funding. (3/9/10)
  Posted 3/8/10 at 10:34pm via onbiovc.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 3/9/10

Sources

1. Eleven Biotherapeutics, Inc.: Series A $35M (onbiovc.com) [edit]
2. Eleven Biotherapeutics rakes in $20M fundraise (masshightech.com) [edit]